All terms in EFO
| Label | Id | Description |
|---|---|---|
| Specific learning disability | HP_0001328 | [Impairment of certain skills such as reading or writing, coordination, self-control, or attention that interfere with the ability to learn. The impairment is not related to a global deficiency of intelligence.] |
| fasudil hydrochloride | CHEBI_31593 | |
| triacylglycerol 52:6 measurement | EFO_0010418 | [The quantification of triacylglycerol 52:6 levels in some body fluid, used as a biomarker for disease.] |
| GM02767 | CLO_0014806 | [ANEUPLOID CHROMOSOME NUMBER - TRISOMY TRISOMY 21] |
| triacylglycerol 54:1 measurement | EFO_0010419 | [The quantification of triacylglycerol 54:1 levels in some body fluid, used as a biomarker for disease.] |
| triacylglycerol 52:4 measurement | EFO_0010416 | [The quantification of triacylglycerol 52:4 levels in some body fluid, used as a biomarker for disease.] |
| triacylglycerol 52:5 measurement | EFO_0010417 | [The quantification of triacylglycerol 52:5 levels in some body fluid, used as a biomarker for disease.] |
| triacylglycerol 52:2 measurement | EFO_0010414 | [The quantification of triacylglycerol 52:2 levels in some body fluid, used as a biomarker for disease.] |
| triacylglycerol 52:3 measurement | EFO_0010415 | [The quantification of triacylglycerol 52:3 levels in some body fluid, used as a biomarker for disease.] |
| death by undetermined cause | EFO_0009434 | [A death that can't be attributed to any precise cause.] |
| triacylglycerol 54:5 measurement | EFO_0010423 | [The quantification of triacylglycerol 54:5 levels in some body fluid, used as a biomarker for disease.] |
| core of nucleus accumbens | UBERON_0012170 | |
| nucleus accumbens | UBERON_0001882 | [A region of the brain consisting of a collection of neurons located in the forebrain ventral to the caudate and putamen. (caudoputamen in rodent) and continuous with these structures. There is no distinct boundary between the nucleus accumbens and the caudate/putamen, but in rodents, it can be identified by its lack of traversing fiber bundles in comparison to the dorsal striatum. Its principle neuron is the medium spiny neuron. Together with the neostriatum (caudate nucleus and putamen), the nucleus accumbens forms the striatum.] |
| arthritis disease activity score measurement | EFO_0009435 | [Quantification of the global severity of rheumatoid arthritis in a patient, based on a combination of several different specific measures, e.g. swollen 28-joint count, tender 28-joint count, erythrocyte sedimentation rate and patient global health assessment score.] |
| rheumatoid arthritis | EFO_0000685 | [Rheumatoid arthritis is a rheumatologic disorder described as an autoimmune disease that is usually a chronic disease and is characterized especially by pain, stiffness, inflammation, swelling, and sometimes destruction of joints., A chronic, systemic autoimmune disorder characterized by inflammation in the synovial membranes and articular surfaces. It manifests primarily as a symmetric, erosive polyarthritis that spares the axial skeleton and is typically associated with the presence in the serum of rheumatoid factor., A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated., An arthritis that results_from an autoimmune disease which attacks healthy cells and tissue located_in joint.] |
| triacylglycerol 54:6 measurement | EFO_0010424 | [The quantification of triacylglycerol 54:6 levels in some body fluid, used as a biomarker for disease.] |
| triacylglycerol 54:3 measurement | EFO_0010421 | [The quantification of triacylglycerol 54:3 levels in some body fluid, used as a biomarker for disease.] |
| offspring survival measurement | EFO_0009436 | [Quantification of the ability of an individual's offspring to survive or live successfully, e.g. the number of children surviving to a given age.] |
| ataxia - deafness - intellectual disability syndrome | MONDO_0008838 | [This syndrome is characterised by progressive ataxia beginning during childhood, deafness and intellectual deficit.] |
| X-linked deafness | MONDO_0020768 |